Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
Open Access
Abstract
The development of drug resistance is one of the main causes of cancer treatment failure. This phenomenon occurs very frequently in different types of cancer, including colon and pancreatic cancers. However, the underlying molecular mechanisms are not fully understood. In recent years, nanomedicine has improved the delivery and efficacy of drugs, and has decreased their side effects. In addition, it has allowed to design drugs capable of avoiding certain resistance mechanisms of tumors. In this article, we review the main resistance mechanisms in colon and pancreatic cancers, along with the most relevant strategies offered by nanodrugs to overcome this obstacle. These strategies include the inhibition of efflux pumps, the use of specific targets, the development of nanomedicines affecting the environment of cancer-specific tissues, the modulation of DNA repair mechanisms or RNA (miRNA), and specific approaches to damage cancer stem cells, among others. This review aims to illustrate how advanced nanoformulations, including polymeric conjugates, micelles, dendrimers, liposomes, metallic and carbon-based nanoparticles, are allowing to overcome one of the main limitations in the treatment of colon and pancreatic cancers. The future development of nanomedicine opens new horizons for cancer treatment.Keywords
Funding Information
- Consejería de Salud, Junta de Andalucía (PI-0102-2017, P18-HO-3882)
- Instituto de Salud Carlos III (PI19/01478)
This publication has 190 references indexed in Scilit:
- Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticlesBiomaterials, 2013
- Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancerBiomaterials, 2013
- Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cellsBMC Cancer, 2012
- Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cellsGenome Integrity, 2012
- The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood–brain barrierNuclear Medicine and Biology, 2012
- Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticlesInternational Journal of Nanomedicine, 2011
- Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In VivoPLOS ONE, 2011
- Chemical Composition of Five Commercial Gynostemma pentaphyllum Samples and Their Radical Scavenging, Antiproliferative, and Anti-inflammatory PropertiesJournal of Agricultural and Food Chemistry, 2010
- Mechanisms and strategies to overcome multiple drug resistance in cancerFEBS Letters, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005